UnitedHealthcare Prior Authorization Lookup
- UnitedHealthcare coverage criteria
- UnitedHealthcare contact directory
- All UnitedHealthcare policy updates
Latest UnitedHealthcare prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Adzynma (ADAMTS13, Recombinant-Krhn) (for Ohio Only)Ohio-only medical benefit drug policy governing coverage and prior authorization for Adzynma in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Albuterol Tablets Prior AuthorizationThis policy governs UnitedHealthcare prior authorization and medical-necessity coverage for albuterol tablets in adults and children age 6 years and older with obstructive airway disease.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Benlysta (belimumab) Coverage CriteriaPrior authorization and reauthorization criteria for subcutaneous Benlysta in patients aged 5 years and older with systemic lupus erythematosus or active lupus nephritis receiving standard therapy.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Carbaglu (carglumic acid) Coverage CriteriaThis policy governs prior authorization and reauthorization for Carbaglu in pediatric and adult patients with hyperammonemia associated with N-acetylglutamate synthase deficiency, propionic acidemia, or methylmalonic acidemia. Coverage requires an eligible diagnosis for initial authorization and documentation of positive clinical response for reauthorization.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Cosmetic, Reconstructive, or Plastic SurgeryCoverage and prior authorization requirements for cosmetic, reconstructive, and plastic surgery services for UnitedHealthcare California HMO and EPO/POS members.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Duvyzat (givinostat) Coverage CriteriaThis policy governs UnitedHealthcare prior authorization and reauthorization for Duvyzat oral suspension for Duchenne muscular dystrophy in patients 6 years of age or older, subject to stated clinical criteria, benefit terms, and applicable utilization-management processes.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Duvyzat (givinostat) Coverage for Duchenne Muscular DystrophyThis policy governs prior authorization and medical-necessity coverage for Duvyzat oral suspension in patients with Duchenne muscular dystrophy. It applies to providers requesting initial or continued therapy for eligible patients.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Electric Tumor Treatment Field Therapy (for Pennsylvania Only)Pennsylvania Medicaid managed-care coverage and prior authorization for FDA-approved electric tumor treatment field devices used for newly diagnosed or recurrent supratentorial glioblastoma.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Encelto (Revakinagene Taroretcel-Lwey) for Ohio OnlyUnitedHealthcare Community Plan medical benefit drug policy governing coverage of Encelto for adults with idiopathic macular telangiectasia type 2 in Ohio, subject to medical-necessity criteria, prior authorization, dosing limits, and applicable Ohio requirements.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01FcRn BlockersCommercial medical-benefit coverage and prior authorization for healthcare-professional-administered FcRn blockers used to treat generalized myasthenia gravis and CIDP, including Imaavy, Rystiggo, Vyvgart, and Vyvgart Hytrulo.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01FcRn BlockersThis policy governs prior authorization and medical benefit coverage for healthcare-professional-administered FcRn blockers used primarily for generalized myasthenia gravis and, for Vyvgart Hytrulo, chronic inflammatory demyelinating polyneuropathy. It applies to UnitedHealthcare Community Plan members except where state-specific Medicaid policies or drug-code policies govern.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Gene Therapy Clinical GuidelineThis guideline governs UnitedHealthcare coverage and prior authorization requirements for FDA-approved gene and cellular therapies used to treat specified inherited hematologic, neurologic, metabolic, and dermatologic disorders. It affects providers requesting gene therapy for eligible pediatric and adult patients.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Hympavzi (marstacimab-hncq) Coverage CriteriaThis policy governs prior authorization and reauthorization for Hympavzi used for routine prophylaxis to prevent or reduce bleeding episodes in members aged 6 years and older with hemophilia A or hemophilia B under UnitedHealthcare commercial pharmacy coverage.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Ibrance (palbociclib) Step TherapyThis policy governs prior authorization and step therapy coverage for Ibrance in members, primarily those with HR-positive, HER2-negative advanced, metastatic, recurrent unresectable, or stage IV breast cancer. Members new to Ibrance must satisfy applicable coverage criteria, while members currently receiving Ibrance may continue therapy when continuation conditions are met.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Inhaled Nitric Oxide Therapy (for Pennsylvania Only)This Pennsylvania-only UnitedHealthcare Community Plan policy governs coverage and prior authorization review for inhaled nitric oxide therapy, primarily for infants with hypoxic respiratory failure or persistent pulmonary hypertension of the newborn.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Juxtapid (lomitapide) Coverage CriteriaThis policy governs UnitedHealthcare prior authorization and medical-necessity coverage for Juxtapid in members with homozygous familial hypercholesterolemia. It establishes initial authorization, reauthorization, step-therapy, documentation, prescriber, combination-therapy, and authorization-duration requirements.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Long-Acting Injectable Antiretroviral Agents for HIVUnitedHealthcare Community Plan Medical Benefit Drug Policy governing coverage and prior authorization for Apretude, Cabenuva, Sunlenca, and Yeztugo injections used for HIV prevention or treatment, subject to specified state Medicaid policies or guidelines.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Luxturna (Voretigene Neparvovec-Rzyl)This UnitedHealthcare Community Plan Medical Benefit Drug Policy governs prior authorization and medical-necessity coverage for Luxturna, a gene therapy for patients with confirmed biallelic RPE65 mutation-associated inherited retinal dystrophy, subject to state-specific policy exceptions and applicable benefit requirements.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Medical Therapies for Enzyme DeficienciesUnitedHealthcare Community Plan coverage and prior authorization for specified enzyme replacement, enzyme-substitution, and related therapies for inherited enzyme deficiencies, with state-specific Medicaid exceptions.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Mirvaso and Rhofade for RosaceaThis policy governs prior authorization and reauthorization for Mirvaso (brimonidine 0.33% topical gel) and Rhofade (oxymetazoline 1% topical cream) for adult patients with rosacea. It applies to providers submitting requests under the UnitedHealthcare commercial pharmacy benefit.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Mulpleta (lusutrombopag) CoverageThis policy governs prior authorization and medical-necessity coverage for Mulpleta (lusutrombopag) in adults with thrombocytopenia associated with chronic liver disease who are scheduled to undergo a procedure. Approval requires specified clinical criteria, including failure, contraindication, or intolerance to Doptelet (avatrombopag).All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Nuedexta Coverage for Pseudobulbar AffectThis policy governs UnitedHealthcare prior authorization and medical-necessity coverage for Nuedexta (dextromethorphan/quinidine) for members with pseudobulbar affect. It applies to initial authorization and reauthorization requests in the commercial pharmacy benefit.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Radicava ORS (edaravone) Coverage CriteriaThis policy governs prior authorization and reauthorization for Radicava ORS used to treat amyotrophic lateral sclerosis (ALS) under UnitedHealthcare pharmacy benefits.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Respiratory Interleukin-5 InhibitorThis policy governs UnitedHealthcare Commercial and Individual Exchange coverage and prior authorization for provider-administered Cinqair, Exdensur, Fasenra, and Nucala used for eosinophilic granulomatosis with polyangiitis or severe eosinophilic asthma. It also specifies benefit routing, authorization duration, prescriber requirements, combination-therapy exclusions, and continuation criteria.All UnitedHealthcare updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Somavert (pegvisomant) Coverage for AcromegalyThis policy governs prior authorization and reauthorization for Somavert (pegvisomant) used to treat acromegaly under UnitedHealthcare pharmacy benefits, subject to member-specific benefit terms and applicable regulatory requirements.All UnitedHealthcare updates
Tool Description
Search UnitedHealthcareprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.